PARUS HOLDINGS, INC. V. GOOGLE LLC -
Before Lourie, Bryson, and Reyna. Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board.
Summary: PTAB did not err in declining to consider...more
COMMSCOPE TECHNOLOGIES LLC v. DALI WIRELESS INC.
Before Stoll, Reyna, and Schall. Appeal from U.S. District Court for the Northern District of Texas.
Summary: When a party distinguishes technology in the prior art to...more
VIDSTREAM LLC V. TWITTER, INC.
Before Newman, O’Malley, and Taranto. Appeal from the Patent Trial and Appeal Board.
Summary: Evidence of a prior art reference’s publication date submitted after an IPR petition may be...more
BIOGEN MA INC. v. EMD SERONO, INC.
Before Newman, Linn, and Hughes. Appeal from the District Court of the District of New Jersey.
Summary: A known method of administering a known product made by a new process is not...more
ALACRITECH, INC. V. INTEL CORP., CAVIUM, LLC, DELL, INC.
Before Stoll, Chen, and Moore. Appeal from the Patent Trial and Appeal Board.
Summary: The PTAB’s obviousness determination must meet the Administrative Procedure...more
HOSPIRA, INC. V. FRESENIUS KABI USA, LLC -
Before Lourie, Dyk, and Moore. Appeal from the U.S. District Court for the Northern District of Illinois.
Summary: Evidence of the properties of claimed embodiments may be...more
1/13/2020
/ Admissible Evidence ,
Appeals ,
Extrinsic Evidence ,
Hospira ,
Inherency ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Validity ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Reaffirmation
TECHTRONIC INDUSTRIES CO. LTD. v. ITC -
Before Lourie, Dyk, and Wallach. Appeal from the U.S. International Trade Commission.
Summary: Consistent description in the specification of a particular embodiment as the...more
12/13/2019
/ Administrative Law Judge (ALJ) ,
Appeals ,
Claim Construction ,
Imports ,
International Trade Commission (ITC) ,
Noninfringement ,
Patent Infringement ,
Patents ,
Prior Art ,
Reversal ,
Scope of the Claim ,
Summary Judgment ,
Vacated ,
Written Descriptions
TELEFONAKTIEBOLAGET LM ERICSSON v. TCL CORPORATION -
Before NEWMAN, LOURIE, and CLEVENGER. Appeal from the Patent Trial and Appeal Board.
Summary: Publications shelved in publicly accessible libraries may be publicly...more
11/11/2019
/ Appeals ,
Declaration ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Printed Publications ,
Prior Art ,
Reaffirmation ,
Reversible Error
Federal Circuit Summary -
Before Lourie, Dyk and Taranto. Consolidated Appeals from the Patent Trial and Appeal Board and the Southern District of California.
Summary: A person is a joint inventor of the anticipating...more
2/4/2019
/ Anticipation ,
Appeals ,
Claim Construction ,
Inter Partes Review (IPR) Proceeding ,
Joint Inventors ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Reaffirmation ,
Reversal ,
Section 102 ,
Summary Judgment
Federal Circuit Summary -
Before Judges Reyna, Bryson, and Stoll. Appeals from the Patent Trial and Appeal Board and the United States District Court for the District of Delaware.
Summary: Non-prior art evidence may...more
10/17/2018
/ Appeals ,
Evidence ,
Multi-Party Litigation ,
Mylan Pharmaceuticals ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
POSITA ,
Prior Art ,
Reaffirmation ,
Sandoz ,
Teva Pharmaceuticals
Federal Circuit Summaries -
Before Taranto, Plager, and Chen. Appeal from the Patent Trials and Appeals Board.
Summary: In determining whether materials distributed at meetings or conferences are reasonably accessible...more
Federal Circuit Summaries -
Before Lourie, O’Malley, and Hughes. Appeal from the Patent Trial and Appeal Board.
Summary: Evaluation of “teaching away” requires consideration of whether a reference “criticize[s],...more
2/12/2018
/ Appeals ,
Broadest Reasonable Interpretation Standard ,
Claim Construction ,
Evidence ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Invalidity ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Reaffirmation ,
Reversal
The Federal Circuit affirmed the PTAB’s final written decision holding that claims directed to Novartis’s multiple sclerosis drug Gilenya were obvious in Novartis AG v. Torrent Pharmaceuticals. Ltd., No. 2016-1352 (Fed. Cir....more